321 related articles for article (PubMed ID: 25268200)
21. Screening and differential diagnosis of renal light chain-associated diseases.
Gerth J; Sachse A; Busch M; Illner N; Muegge LO; Gröne HJ; Wolf G
Kidney Blood Press Res; 2012; 35(2):120-8. PubMed ID: 22056791
[TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.
Ronco P; Plaisier E; Mougenot B; Aucouturier P
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367
[TBL] [Abstract][Full Text] [Related]
23. Proliferative glomerulonephritis with discrete deposition of monoclonal immunoglobulin γ1 CH 2 heavy chain and κ light chain: a new variant of monoclonal immunoglobulin deposition disease.
Komatsuda A; Ohtani H; Sawada K; Joh K; Wakui H
Pathol Int; 2013 Jan; 63(1):63-7. PubMed ID: 23356227
[TBL] [Abstract][Full Text] [Related]
24. Crystalline light chain proximal tubulopathy with chronic renal failure and silicone gel breast implants: 1 case report.
Figueres ML; Beaume J; Vuiblet V; Rabant M; Bassilios N; Herody M; Touchard G; Noël LH
Hum Pathol; 2015 Jan; 46(1):165-8. PubMed ID: 25454480
[TBL] [Abstract][Full Text] [Related]
25. Circulating monoclonal light chains and acute kidney injury: the role of the renal biopsy with emphasis on ultrastructural evaluation in assessing and understanding renal injury.
Aufman J; Herrera GA
Ultrastruct Pathol; 2015 May; 39(3):159-68. PubMed ID: 25856088
[TBL] [Abstract][Full Text] [Related]
26. Ultrastructural immunolabeling in the diagnosis of monoclonal light-and heavy-chain-related renal diseases.
Herrera GA; Turbat-Herrera EA
Ultrastruct Pathol; 2010 May; 34(3):161-73. PubMed ID: 20455664
[TBL] [Abstract][Full Text] [Related]
27. Lambda light chain deposition disease in a renal allograft.
Tanenbaum ND; Howell DN; Middleton JP; Spurney RF
Transplant Proc; 2005 Dec; 37(10):4289-92. PubMed ID: 16387099
[TBL] [Abstract][Full Text] [Related]
28. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases.
Buxbaum J; Gallo G
Hematol Oncol Clin North Am; 1999 Dec; 13(6):1235-48. PubMed ID: 10626147
[TBL] [Abstract][Full Text] [Related]
29. Myeloma kidney with isolated tubulointerstitial light chain deposition in a renal allograft.
Balamuthusamy S; Hamrahian M; Zhang R; Batuman V
Clin Transplant; 2009; 23(6):848-52. PubMed ID: 19210683
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic significance of kappa/lambda and lambda/kappa ratio in paraproteinemias.
Tichý M; Hrncír Z
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1982; 25(3-4):313-8. PubMed ID: 6820852
[No Abstract] [Full Text] [Related]
31. Lambda-light-chain nephropathy with Fanconi's syndrome.
Thorner PS; Bédard YC; Fernandes BJ
Arch Pathol Lab Med; 1983 Dec; 107(12):654-7. PubMed ID: 6416221
[TBL] [Abstract][Full Text] [Related]
32. [Cutaneous manifestations revealing cryofibrinogenaemia associated with monoclonal gammopathy].
Delyon J; Bezier M; Cordoliani F; Malphettes M; Szalat R; Bagot M; Rybojad M
Ann Dermatol Venereol; 2013 Jan; 140(1):30-5. PubMed ID: 23328357
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal immunoglobulin deposition disease associated with membranous features.
Komatsuda A; Masai R; Ohtani H; Togashi M; Maki N; Sawada K; Wakui H
Nephrol Dial Transplant; 2008 Dec; 23(12):3888-94. PubMed ID: 18596130
[TBL] [Abstract][Full Text] [Related]
34. Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.
Sethi S; Fervenza FC; Rajkumar SV
Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):127-37. PubMed ID: 26735145
[TBL] [Abstract][Full Text] [Related]
35. Tubular Injury and Dendritic Cell Activation Are Integral Components of Light Chain-Associated Acute Tubulointerstitial Nephritis.
Cheng M; Gu X; Turbat-Herrera EA; Herrera GA
Arch Pathol Lab Med; 2019 Oct; 143(10):1212-1224. PubMed ID: 31063013
[TBL] [Abstract][Full Text] [Related]
36. Light chain nephropathy: histological and clinical aspects in 15 cases.
Confalonieri R; Barbiano di Belgiojoso G; Banfi G; Ferrario F; Bertani T; Pozzi C; Casanova S; Lupo A; De Ferrari G; Minetti L
Nephrol Dial Transplant; 1988; 3(2):150-6. PubMed ID: 3140081
[TBL] [Abstract][Full Text] [Related]
37. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis.
Nasr SH; Said SM; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Dispenzieri A; Buadi FK; Vrana JA; Theis JD; Dogan A; Leung N
Kidney Int; 2013 Mar; 83(3):463-70. PubMed ID: 23302715
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxicity of myeloma light chains in cultured human kidney proximal tubule cells.
Pote A; Zwizinski C; Simon EE; Meleg-Smith S; Batuman V
Am J Kidney Dis; 2000 Oct; 36(4):735-44. PubMed ID: 11007675
[TBL] [Abstract][Full Text] [Related]
39. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma.
Iványi B
Arch Pathol Lab Med; 1990 Sep; 114(9):986-7. PubMed ID: 2117910
[TBL] [Abstract][Full Text] [Related]
40. Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement.
Jacquot C; Saint-Andre JP; Touchard G; Nochy D; D'Auzac de Lamartinie C; Oriol R; Druet P; Bariety J
Clin Nephrol; 1985 Aug; 24(2):93-8. PubMed ID: 3930115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
